APA (7th ed.) Citation

D'Antiga, L., Beuers, U., Brunetti-Pierri, N., Baumann, U., Di Giorgio, A., Aronson, S., . . . Labrune, P. (2022). Gene therapy for Crigler Najjar syndrome: Results of the dose finding part of the CareCN, phase 1-2 clinical trial. Journal of pediatric gastroenterology and nutrition, 74, 674. https://doi.org/10.1097/MPG.0000000000003446

Chicago Style (17th ed.) Citation

D'Antiga, L., et al. "Gene Therapy for Crigler Najjar Syndrome: Results of the Dose Finding Part of the CareCN, Phase 1-2 Clinical Trial." Journal of Pediatric Gastroenterology and Nutrition 74 (2022): 674. https://doi.org/10.1097/MPG.0000000000003446.

MLA (9th ed.) Citation

D'Antiga, L., et al. "Gene Therapy for Crigler Najjar Syndrome: Results of the Dose Finding Part of the CareCN, Phase 1-2 Clinical Trial." Journal of Pediatric Gastroenterology and Nutrition, vol. 74, 2022, p. 674, https://doi.org/10.1097/MPG.0000000000003446.